Vytorin

Vytorin

(vī′tə-rĭn)
A trademark for a combination of the drugs simvastatin and ezetimibe.
References in periodicals archive ?
Merck will seek Food and Drug Administration approval for Vytorin use in patients with chronic kidney disease (CKD) based on the SHARP trial results, the company said.
We would expect Zetia and Vytorin prescriptions to show further declines.
WASHINGTON -- The House Energy and Commerce Committee wants the Food and Drug Administration to turn over the results of an analysis about the potential links between cancer and the cholesterol drug Vytorin, which is sold jointly by Merck & Co.
1 billion when it was announced in March, would unite the makers of the cholesterol drugs Zetia and Vytorin.
An immediate independent analysis of cancer incidence and mortality among 20,000 patients treated so far in two other ongoing Vytorin trials, SHARP (the Study of Heart and Renal Protection) and IMPROVE-IT (the Improved Reduction of Outcomes: Vytorin Efficacy International Trial), found no increased risk, but doubts have remained.
WASHINGTON -- A congressional committee investigating whether the marketers of the cholesterol drug Vytorin withheld data that would hurt sales has released new evidence that critics contend supports such suspicions.
s cholesterol drug Vytorin (ezetimibe/simvastatin), which generated U.
Vytorin had annual sales of approximately $678 million in the U.
M2 EQUITYBITES-April 27, 2017-Impax passes US FDA approval for generic Vytorin ezetimibe/simvastatin tablets